To Evaluate Post Operative Pain Using Two Different Kind of Sealers in Obturation of Teeth With Symptomatic Irreversible Pulpitis During Second Visit When the Patient is Painless

Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18-40
SponsorJaweria Gul Keyani

About this trial

The goal of this randomized clinical trial is to evaluate pain after root canal treatment using two different kinds of sealers during obturation in 60 healthy , male and female patients ages between 18 to 40 years. The main aims is to systematically evaluate and compare post-operative pain levels in patients undergoing root canal treatment with two different types of endodontic sealers: AH plus (SEAL APEX) and bio ceramic sealer(META)

• By identifying the sealer that leads to the least discomfort, this research could significantly enhance patient care, minimize recovery time, and improve overall treatment success in endodontics.

Participants in both groups will be given a visual analogue scale(VAS) to measure the pain level after the root canal treatment has been completed. They will measure pain levels at 12, 24 and 48 hours. All information will be recorded on proforma and compared.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

• Patients ranging from 18 to 40 years.

Patients whose teeth have been diagnosed with Symptomatic irreversible pulpitis.

maxillary and mandibular teeth.

A normal periapical condition on radiograph, or one with little to no periodontal ligament (PDL) space widening, confirming the normal periapical state.

Disqualifiers

Non-restorable teeth.

Patients with poor health whose systemic complications could change the course of treatment.

Teeth with immature roots.

Teeth with periapical lesions or apical periodontitis.

Trial design

Design model

Parallel

Treatments tested in this trial

  • AH-Plus Epoxy Resin Sealer

    Drug

    AH plus sealer is an epoxy resin based sealer that is biocompatible with good sealing ability

  • bioceramic sealer

    Drug

    MTA based sealers,biocermic sealers are biocompatible, safe to use

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Group A , AH plus sealer , Group B ( bioceramic sealer)Active comparator 1 intervention
Group B: Group A , (AH plus sealer ) , Group B ( bioceramic sealer)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

post operative pain in both sealer groups after obturation

Post-operative pain levels will be measured and compared in both groups using Visual Analogue Scale (VAS) Patients were asked to rate their pain on a numerical scale from 0 to 10, where 0 indicated no pain and 10 indicated the worst pain imaginable. For interpretation, pain intensity was categorized as follows: 1-3: Mild pain 4-6: Moderate pain 7-10: Severe pain

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jaweria Gul Keyani

Lead sponsor

Margalla Institute of Health Sciences

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: